Simple and Rapid Assay to Detect Acute Subtype B and Group M HIV-1 Infections
Within recent years, point-of-care (POC) testing has allowed for many individuals to be screened for and provided with HIV test results. It is critical to be able to accurately detect acute HIV infections as this is a stage where the risk of transmission is great. Additionally, early HIV detection could lead to less high-risk behavior, thereby reducing transmission. Currently, there are no rapid, cost-effective diagnostic tests sensitive enough to detect acute HIV-1 infections for the POC setting.
Researchers at the CDC have developed an HIV-1 detection assay using reverse-transcription loop-mediated isothermal amplification (RT-LAMP) that is quick, easy to perform, and does not require complex, dedicated equipment or laboratory space. These features are ideal for POC and could increase the percentage of individuals who receive their HIV status, while immediately linking them to counseling and medical care. Also, the early knowledge of their HIV status could lead to reduced high-risk behavior at a time when individuals exhibit a greater risk for transmitting the virus.
Potential Commercial Applications: | Competitive Advantages: |
|
|
Related Invention(s):
E-173-2013-0
Inventors:
Sherry Owen (CDC) ➽ more inventions...
Kelly Curtis (CDC) ➽ more inventions...
Donna Rudolph (CDC) ➽ more inventions...
Philip Niedzwiedz (CDC) ➽ more inventions...
Intellectual Property:
U.S. Pat: 10,697,028 issued 2020-06-30
PCT Application No. PCT/US2015/057861
US Application No. 15/524,209
Publications:
Curtis KA, et al. PMID 22384022
Licensing Contact:
Jeremiah Mitzelfelt,
Email: jeremiah.mitzelfelt@nih.gov
Phone: 301-443-8518
OTT Reference No: E-014-2015-0
Updated: Mar 15, 2017